304 related articles for article (PubMed ID: 35249876)
1. [Mechanism of valproic acid-induced dendritic spine and synaptic impairment in the prefrontal cortex for causing core autistic symptoms in mice].
Wang F; Wang L; Xiong Y; Deng J; Lü M; Tang B; Zhang X; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):101-107. PubMed ID: 35249876
[TBL] [Abstract][Full Text] [Related]
2. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
3. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
4. Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism.
Li Z; You M; Che X; Dai Y; Xu Y; Wang Y
Ecotoxicol Environ Saf; 2021 Apr; 212():112000. PubMed ID: 33550075
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder.
Zhang J; Zhang JX; Zhang QL
Brain Res Bull; 2016 Jul; 125():152-8. PubMed ID: 27320472
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
7. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
Yamaguchi H; Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Behav Brain Res; 2017 Aug; 333():67-73. PubMed ID: 28655565
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
9. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Hara Y; Ago Y; Taruta A; Katashiba K; Hasebe S; Takano E; Onaka Y; Hashimoto H; Matsuda T; Takuma K
Autism Res; 2016 Sep; 9(9):926-39. PubMed ID: 26714434
[TBL] [Abstract][Full Text] [Related]
10. Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.
Mahmood U; Ahn S; Yang EJ; Choi M; Kim H; Regan P; Cho K; Kim HS
Pharmacol Res; 2018 Feb; 128():110-121. PubMed ID: 28823725
[TBL] [Abstract][Full Text] [Related]
11. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid.
Nicolini C; Ahn Y; Michalski B; Rho JM; Fahnestock M
Acta Neuropathol Commun; 2015 Jan; 3():3. PubMed ID: 25627160
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid.
Gąssowska-Dobrowolska M; Kolasa-Wołosiuk A; Cieślik M; Dominiak A; Friedland K; Adamczyk A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809910
[TBL] [Abstract][Full Text] [Related]
13. Maternal treatment with aripiprazole prevents the development of a valproic acid-induced autism-like phenotype in juvenile male mice.
de Oliveira Ferreira E; Pessoa Gomes JM; Neves KRT; Lima FAV; de Barros Viana GS; de Andrade GM
Behav Pharmacol; 2023 Apr; 34(2-3):154-168. PubMed ID: 36853856
[TBL] [Abstract][Full Text] [Related]
14. Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1/p38 MAPK pathway.
Xiong Y; Chen J; Lv M; Wang F; Zhang H; Tang B; Li Y
Int Immunopharmacol; 2023 Apr; 117():109885. PubMed ID: 36842231
[TBL] [Abstract][Full Text] [Related]
15. Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features.
Zhou L; Jiang P; Zhao L; Fei X; Tang Y; Luo Y; Gong H; Wang X; Li X; Li S; Zhang C; Yang H; Fan X
Phytomedicine; 2024 Apr; 126():155443. PubMed ID: 38394737
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
17. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
18. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
[TBL] [Abstract][Full Text] [Related]
19. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
20. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model.
Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D
Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
